1. Home
  2. GSIT vs CUE Comparison

GSIT vs CUE Comparison

Compare GSIT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIT
  • CUE
  • Stock Information
  • Founded
  • GSIT 1995
  • CUE 2014
  • Country
  • GSIT United States
  • CUE United States
  • Employees
  • GSIT N/A
  • CUE N/A
  • Industry
  • GSIT Semiconductors
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIT Technology
  • CUE Health Care
  • Exchange
  • GSIT Nasdaq
  • CUE Nasdaq
  • Market Cap
  • GSIT 58.5M
  • CUE 60.6M
  • IPO Year
  • GSIT N/A
  • CUE 2018
  • Fundamental
  • Price
  • GSIT $2.61
  • CUE $0.76
  • Analyst Decision
  • GSIT
  • CUE Strong Buy
  • Analyst Count
  • GSIT 0
  • CUE 3
  • Target Price
  • GSIT N/A
  • CUE $3.00
  • AVG Volume (30 Days)
  • GSIT 170.6K
  • CUE 206.6K
  • Earning Date
  • GSIT 05-01-2025
  • CUE 05-08-2025
  • Dividend Yield
  • GSIT N/A
  • CUE N/A
  • EPS Growth
  • GSIT N/A
  • CUE N/A
  • EPS
  • GSIT N/A
  • CUE N/A
  • Revenue
  • GSIT $19,787,000.00
  • CUE $9,287,000.00
  • Revenue This Year
  • GSIT N/A
  • CUE N/A
  • Revenue Next Year
  • GSIT N/A
  • CUE $4.77
  • P/E Ratio
  • GSIT N/A
  • CUE N/A
  • Revenue Growth
  • GSIT N/A
  • CUE 69.16
  • 52 Week Low
  • GSIT $1.62
  • CUE $0.45
  • 52 Week High
  • GSIT $4.90
  • CUE $2.26
  • Technical
  • Relative Strength Index (RSI)
  • GSIT 54.57
  • CUE 39.49
  • Support Level
  • GSIT $1.62
  • CUE $0.72
  • Resistance Level
  • GSIT $2.85
  • CUE $0.89
  • Average True Range (ATR)
  • GSIT 0.22
  • CUE 0.10
  • MACD
  • GSIT 0.09
  • CUE 0.02
  • Stochastic Oscillator
  • GSIT 80.49
  • CUE 48.59

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Share on Social Networks: